| abstract |
The present invention provides novel β 2 adrenergic receptor agonist compounds of formula (I): wherein R 1 -R 13 and w have any of the values described herein. The present invention also relates to combinations of such compounds with other therapeutic agents, pharmaceutical compositions containing such compounds and combinations, diseases associated with β 2 adrenergic receptor activity using such compounds. As well as processes and intermediates useful for preparing such compounds. |